The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects

Biologic therapies have revolutionized treatment of a number of diseases. Patents and exclusivity for a number of biologics are expiring. This has created the opportunity for the development and approval of biosimilars. Biosimilars are biologic products developed using a step-wise approach to result...

Descripción completa

Detalles Bibliográficos
Autores principales: Declerck, Paul, Danesi, Romano, Petersel, Danielle, Jacobs, Ira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375962/
https://www.ncbi.nlm.nih.gov/pubmed/28258517
http://dx.doi.org/10.1007/s40265-017-0717-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375962/
https://www.ncbi.nlm.nih.gov/pubmed/28258517
http://dx.doi.org/10.1007/s40265-017-0717-1

Ejemplares similares